A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders
- PMID: 23182410
- PMCID: PMC3593793
- DOI: 10.1016/j.drugalcdep.2012.10.017
A randomized study of contingency management in cocaine-dependent patients with severe and persistent mental health disorders
Abstract
Background: Contingency management (CM) is efficacious for reducing drug use, but it has rarely been applied to patients with severe and persistent mental health problems. This study evaluated the efficacy of CM for reducing cocaine use in psychiatric patients treated at a community mental health center.
Methods: Nineteen cocaine-dependent patients with extensive histories of mental health problems and hospitalizations were randomized to twice weekly urine sample testing with or without CM for 8 weeks. In the CM condition, patients earned the chance to win prizes for each cocaine-negative urine sample. Patients also completed an instrument assessing severity of psychiatric symptoms pre- and post-treatment.
Results: Patients assigned to CM achieved a mean (standard deviation) of 2.9 (1.7) weeks of continuous cocaine abstinence versus 0.6 (1.7) weeks for patients in the testing only condition, p=.008, Cohen's effect size d=1.35. Of the 16 expected samples, 46.2% (27.5) were cocaine negative in the CM condition versus 13.8% (27.9) in the testing only condition, p=.02, d=1.17, but proportions of negative samples submitted did not differ between groups. Reductions in psychiatric symptoms were noted over time in CM, but not the testing only, condition, p=.02.
Conclusions: CM yielded benefits for enhancing durations of abstinence in dual diagnosis patients, and it also was associated with reduced psychiatric symptoms. These findings call for larger-scale and longer-term evaluations of CM in psychiatric populations.
Trial registration: ClinicalTrials.gov NCT01478815.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
None.
Figures

References
-
- Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry. 2006;63:426–432. - PubMed
-
- Beutler LE, Engle D, Mohr D, Daldrup RJ, Bergan J, Meredith K, Merry W. Predictors of differential response to cognitive, experiential, and self-directed psychotherapeutic procedures. J Consult Clin Psychol. 1991;59:333–340. - PubMed
-
- Derogatis LR. The Brief Symptom Inventory (BSI): Administration, scoring procedures manual-II. Clinical Psychometric Research; Minneapolis, MN: 1993.
-
- Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res. 1999;35(Suppl):S93–100. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- R01 DA013444/DA/NIDA NIH HHS/United States
- R01 DA022739/DA/NIDA NIH HHS/United States
- P50 DA009241/DA/NIDA NIH HHS/United States
- R01-HD075630/HD/NICHD NIH HHS/United States
- P60-AA03510/AA/NIAAA NIH HHS/United States
- R01-DA022739/DA/NIDA NIH HHS/United States
- R21 DA031897/DA/NIDA NIH HHS/United States
- P60 AA003510/AA/NIAAA NIH HHS/United States
- R01 HD075630/HD/NICHD NIH HHS/United States
- R01-DA027615/DA/NIDA NIH HHS/United States
- R01-DA13444/DA/NIDA NIH HHS/United States
- R01 DA027615/DA/NIDA NIH HHS/United States
- R21-DA031897/DA/NIDA NIH HHS/United States
- P30-DA023918/DA/NIDA NIH HHS/United States
- P30 DA023918/DA/NIDA NIH HHS/United States
- P50-DA09241/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous